- Home
- ASTI vs TCRT Comparison
ASTI vs TCRT Comparison
Compare ASTI & TCRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASTI
- TCRT
- Stock Information
- Founded
- ASTI 2005
- TCRT 1998
- Country
- ASTI United States
- TCRT United States
- Employees
- ASTI N/A
- TCRT N/A
- Industry
- ASTI Semiconductors
- TCRT Biotechnology: Pharmaceutical Preparations
- Sector
- ASTI Technology
- TCRT Health Care
- Exchange
- ASTI Nasdaq
- TCRT Nasdaq
- Market Cap
- ASTI 3.1M
- TCRT 2.6M
- IPO Year
- ASTI N/A
- TCRT N/A
- Fundamental
- Price
- ASTI $2.21
- TCRT $1.68
- Analyst Decision
- ASTI
- TCRT
- Analyst Count
- ASTI 0
- TCRT 0
- Target Price
- ASTI N/A
- TCRT N/A
- AVG Volume (30 Days)
- ASTI 29.2K
- TCRT 12.3K
- Earning Date
- ASTI 03-04-2025
- TCRT 03-31-2025
- Dividend Yield
- ASTI N/A
- TCRT N/A
- EPS Growth
- ASTI N/A
- TCRT N/A
- EPS
- ASTI N/A
- TCRT N/A
- Revenue
- ASTI $44,673.00
- TCRT $7,000.00
- Revenue This Year
- ASTI N/A
- TCRT N/A
- Revenue Next Year
- ASTI N/A
- TCRT N/A
- P/E Ratio
- ASTI N/A
- TCRT N/A
- Revenue Growth
- ASTI N/A
- TCRT N/A
- 52 Week Low
- ASTI $1.90
- TCRT $1.50
- 52 Week High
- ASTI $87.80
- TCRT $26.00
- Technical
- Relative Strength Index (RSI)
- ASTI 43.64
- TCRT 48.71
- Support Level
- ASTI $2.14
- TCRT $1.59
- Resistance Level
- ASTI $2.49
- TCRT $1.70
- Average True Range (ATR)
- ASTI 0.21
- TCRT 0.09
- MACD
- ASTI 0.02
- TCRT 0.01
- Stochastic Oscillator
- ASTI 52.54
- TCRT 69.23
About ASTI Ascent Solar Technologies Inc.
Ascent Solar Technologies Inc is engaged in the manufacturing and selling of photovoltaic products (PV) solar modules that are flexible, durable, and possess attractive power-to-weight and power-to-area performance. The company is integrating its PV products into scalable and high-value markets such as agrivoltaics, aerospace, satellites, near-earth orbiting vehicles, and fixed-wing unmanned aerial vehicles (UAV). Ascent is also working to expand its portable solar chargers, such as the XD-12. The company markets and sells its products through OEMs, system integrators, distributors, retailers, and e-commerce companies.
About TCRT Alaunos Therapeutics Inc.
Alaunos Therapeutics Inc is a clinical-stage cellular immuno-oncology company dedicated to the treatment of solid tumors through adoptive TCR-T cell therapy. It strikes cancer at its core by engineering cell therapies that target Neoantigens arising from genomic mutations.